130 related articles for article (PubMed ID: 9517418)
1. A novel kainate receptor ligand [3H]-(2S,4R)-4-methylglutamate: pharmacological characterization in rabbit brain membranes.
Toms NJ; Reid ME; Phillips W; Kemp MC; Roberts PJ
Neuropharmacology; 1997; 36(11-12):1483-8. PubMed ID: 9517418
[TBL] [Abstract][Full Text] [Related]
2. Regional mapping of low-affinity kainate receptors in mouse brain using [(3)H](2S,4R)-4-methylglutamate autoradiography.
Bailey A; Kelland EE; Thomas A; Biggs J; Crawford D; Kitchen I; Toms NJ
Eur J Pharmacol; 2001 Nov; 431(3):305-10. PubMed ID: 11730722
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain.
Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
Br J Pharmacol; 1995 Oct; 116(3):2033-9. PubMed ID: 8640342
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of low affinity kainate receptors in brain of Macaca fascicularis determined by autoradiography using [3H](2S,4R)-4-methylglutamate.
Carroll FY; Finkelstein DI; Horne MK; Lawrence AJ; Crawford D; Paxinos G; Beart PM
Neurosci Lett; 1998 Oct; 255(2):71-4. PubMed ID: 9835217
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate.
Jones KA; Wilding TJ; Huettner JE; Costa AM
Neuropharmacology; 1997 Jun; 36(6):853-63. PubMed ID: 9225313
[TBL] [Abstract][Full Text] [Related]
6. (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors.
Zhou LM; Gu ZQ; Costa AM; Yamada KA; Mansson PE; Giordano T; Skolnick P; Jones KA
J Pharmacol Exp Ther; 1997 Jan; 280(1):422-7. PubMed ID: 8996224
[TBL] [Abstract][Full Text] [Related]
7. The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors.
Donevan SD; Beg A; Gunther JM; Twyman RE
J Pharmacol Exp Ther; 1998 May; 285(2):539-45. PubMed ID: 9580595
[TBL] [Abstract][Full Text] [Related]
8. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine.
Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471
[TBL] [Abstract][Full Text] [Related]
9. LY339434, a GluR5 kainate receptor agonist.
Small B; Thomas J; Kemp M; Hoo K; Ballyk B; Deverill M; Ogden AM; Rubio A; Pedregal C; Bleakman D
Neuropharmacology; 1998; 37(10-11):1261-7. PubMed ID: 9849663
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites.
Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T
J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons.
Bleakman D; Ogden AM; Ornstein PL; Hoo K
Eur J Pharmacol; 1999 Aug; 378(3):331-7. PubMed ID: 10493110
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic characterization of [3H]6-cyano-7-nitroquinoxaline-2,3-dione binding sites in adult chick brain.
Zavitsanou K; Mitsacos A; Kouvelas ED
Neuroscience; 1994 Oct; 62(3):955-62. PubMed ID: 7532837
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione.
Hatziefthimiou A; Mitsacos A; Kouvelas ED
J Neurosci Res; 1994 Feb; 37(3):392-7. PubMed ID: 7909852
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain.
Dev KK; Petersen V; Honoré T; Henley JM
J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496
[TBL] [Abstract][Full Text] [Related]
15. [(3)H](2S,4R)-4-Methylglutamate: a novel ligand for the characterization of glutamate transporters.
Apricó K; Beart PM; Lawrence AJ; Crawford D; O'Shea RD
J Neurochem; 2001 Jun; 77(5):1218-25. PubMed ID: 11389172
[TBL] [Abstract][Full Text] [Related]
16. Interaction of guanine nucleotides with [3H]kainate and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione binding in goldfish brain.
Barnes JM; Murphy PA; Kirkham D; Henley JM
J Neurochem; 1993 Nov; 61(5):1685-91. PubMed ID: 7901328
[TBL] [Abstract][Full Text] [Related]
17. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
Apricò K; Beart PM; Crawford D; O'Shea RD
J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
[TBL] [Abstract][Full Text] [Related]
18. Comparison of solubilised kainate and alpha-amino-3-hydroxy-5- methylisoxazolepropionate binding sites in chick cerebellum.
Henley JM; Barnard EA
J Neurochem; 1991 Feb; 56(2):702-5. PubMed ID: 1846403
[TBL] [Abstract][Full Text] [Related]
19. Kainate binding to the AMPA receptor in rat brain.
Hall RA; Kessler M; Lynch G
Neurochem Res; 1994 Jun; 19(6):777-82. PubMed ID: 7520541
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea.
Sakai R; Swanson GT; Shimamoto K; Green T; Contractor A; Ghetti A; Tamura-Horikawa Y; Oiwa C; Kamiya H
J Pharmacol Exp Ther; 2001 Feb; 296(2):650-8. PubMed ID: 11160654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
